InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
46 hedge funds and large institutions have $49.8M invested in InVivo Therapeutics Holdings Corp in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 0 reducing their positions, and 8 closing their positions.
125% more call options, than puts
Call options by funds: $5.79M | Put options by funds: $2.57M
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
26% more capital invested
Capital invested by funds: $39.5M → $49.8M (+$10.4M)
21% more funds holding
Funds holding: 38 → 46 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.11M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$2.25M |
| 3 |
Goldman Sachs
New York
|
+$1.5M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$644K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$536K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$737K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$322K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$268K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$213K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$151K |
NVIV Hedge Fund Activity: Q1 2016 in Review
46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2016, worth a combined $49.8M — up 26% from $39.5M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NVIV positions and 8 closed out — a net gain of 8 holders — while 13 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.11M. The largest seller was Wellington Management Group, exiting entirely with an estimated $737K sold.
- 46 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2016, up from 38 in Q4 2015.
- Funds reported $49.8M of InVivo Therapeutics Holdings Corp stock for Q1 2016, up 26% quarter-over-quarter.
- 16 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2016 and 8 closed out, a net change of +8 holders.
- The largest InVivo Therapeutics Holdings Corp buyer in Q1 2016 was Sabby Management, an estimated $3.11M added.
- The largest InVivo Therapeutics Holdings Corp seller in Q1 2016 was Wellington Management Group, an estimated $737K sold.
Based on aggregated 13F filings for Q1 2016.